Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 642,333.36
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 31.48 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 518.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 518.26 Mn
Mar 31, 2026 518.26 Mn
Dec 31, 2025 513.15 Mn
Dec 31, 2025 513.15 Mn
Sep 30, 2025 501.75 Mn
Sep 30, 2025 501.75 Mn
Jun 30, 2025 499.79 Mn
Jun 30, 2025 499.79 Mn
Mar 31, 2025 498.68 Mn
Mar 31, 2025 498.68 Mn
Dec 31, 2024 502.78 Mn
Dec 31, 2024 502.78 Mn
Sep 30, 2024 507.00 Mn
Sep 30, 2024 507.00 Mn
Jun 30, 2024 517.16 Mn
Jun 30, 2024 517.16 Mn
Mar 31, 2024 523.46 Mn
Mar 31, 2024 523.46 Mn
Dec 31, 2023 526.06 Mn
Dec 31, 2023 526.06 Mn